ASSAYS FOR PLASMA COMPLEMENT ACTIVATION BY X-RAY CONTRAST-MEDIA

被引:15
作者
EATON, S [1 ]
TSAY, HM [1 ]
YOST, F [1 ]
TWEEDLE, MF [1 ]
机构
[1] SQUIBB INST MED RES,RT 1 & COLL FARM RD,NEW BRUNSWICK,NJ 08903
关键词
Adverse reactions; C3A and CH 50; Complement activation; X-ray contrast media;
D O I
10.1097/00004424-199007000-00007
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Hemolytic complement activity and a C3a radioimmunoassay (RIA) were investigated for their ability to characterize contrast media (CM) with respect to complement activation. The CM tested were commercial formulations of diatrizoate, iodamide, iothalamate, ioxaglate, iohexol, and iopamidol. When plasma was exposed to CM, the hemolytic complement activity decreased and the C3a concentration increased. The C3a assay had a larger dynamic range and therefore more ability to discriminate among the CM. Using C3a data from pooled plasma or from individual donors’ plasma, nonionic iopamidol (as Isovue 300) had lower complement-activating potential (P<.005 and P>.05, respectively) than all of the ionic media based on diatrizoate, iothalamate, iodamide, and ioxaglate. The ranges of mean C3a values generated by saline, nonionic CM, and ionic CM were 48 to 60, 65 to 173, and 807 to 3272 ng C3a/ 50 µL, respectively. Complement activation was found to correlate with osmolality (r=0.945, all media) and with molarity (r=0.994, diatrizoates). © Lippincott-Raven Publishers.
引用
收藏
页码:789 / 792
页数:4
相关论文
共 18 条
[1]   COMPLEMENT ACTIVATION AND GENERATION OF C3A-ANAPHYLATOXIN BY RADIOLOGICAL CONTRAST AGENTS [J].
DAWSON, P ;
TURNER, MW ;
BRADSHAW, A ;
WESTABY, S .
BRITISH JOURNAL OF RADIOLOGY, 1983, 56 (667) :447-448
[2]  
EATON S, 1987, CLIN CHEM, V33, P1470
[3]   A PREDICTIVE TEST FOR ADVERSE REACTIONS TO CONTRAST-MEDIA - PRELIMINARY-RESULTS [J].
EATON, SM ;
HAGAN, JJ ;
TSAY, HM ;
TWEEDLE, MF ;
NICKOLOFF, EL ;
LOBERG, MD ;
YOST, FJ .
INVESTIGATIVE RADIOLOGY, 1988, 23 :S206-S208
[4]   IOPAMIDOL TOXICOLOGY [J].
FELDER, E .
INVESTIGATIVE RADIOLOGY, 1984, 19 (05) :S168-S170
[5]  
FRITZLER MJ, 1978, CAN MED ASSOC J, V119, P901
[6]  
Kabat EA, 1961, EXPT IMMUNOCHEMISTRY, P133
[7]  
KATAYAMA H, 1988, REPORT JAPANESE COMM
[8]   HUMAN-ENDOTHELIAL CELL-CULTURE AS AN EVALUATION SYSTEM FOR THE TOXICITY OF INTRAVASCULAR CONTRAST-MEDIA [J].
LAERUM, F ;
BORSUM, T ;
REISVAAG, A .
INVESTIGATIVE RADIOLOGY, 1983, 18 (02) :199-206
[9]  
LASSER EC, 1962, AMER J ROENTGENOL RA, V87, P338
[10]  
NEWELL S, 1982, J LAB CLIN MED, V100, P437